Angel round
somefrogs
CEO: Mona Ismail
Founder: Mona Ismail
Founder: Mona Ismail
We are a sector agnostic early-stage investor that wants to partner with founders from the very beginning of their journey and support them throughout their growth. Our team has global experience in building and scaling companies both as founders and in various CxO roles. We invest in ambitious and determined teams that can one day become industry leaders.
New investments
Mona Ismail
Pre-seed round
Synergi
CEO: Antti Hämmäinen
Founders: Antti Hämmäinen, Harri Iisakka, Petrus Holm
Founders: Antti Hämmäinen, Harri Iisakka, Petrus Holm
Seed round
Inven
Founders: Niilo Pirttijärvi, Tommi Kupiainen, Ekku Jokinen
Charlotta Topelius and Niklas Sandler Topelius
Seed round
CurifyLabs
CEO: Charlotta Topelius
Founders: Charlotta Topelius, Niklas Sandler Topelius
Founders: Charlotta Topelius, Niklas Sandler Topelius
Seed round
Hyperion Robotics
CEO: Fernando De los Rios
Founders: Fernando De los Rios, Ashish Mohite, Henry Unterreiner
Founders: Fernando De los Rios, Ashish Mohite, Henry Unterreiner
Angel round
Focal
CEO: Tuomo Riekki
Founders: Tuomo Riekki, Andreas Stenman
Founders: Tuomo Riekki, Andreas Stenman
Seed round
Droppe
CEO: Johannes Salmisaari
Founders: Johannes Salmisaari, Henrik Helenius
Founders: Johannes Salmisaari, Henrik Helenius
Seed round
Mobal
CEO: Jakob Wikström
Founders: Jakob Wikström & Alexander Silén
Founders: Jakob Wikström & Alexander Silén
Seed round
P2X Solutions
CEO: Herkko Plit
Founders: Herkko Plit, Jukka Juola
Founders: Herkko Plit, Jukka Juola
Seed round
Mjuk
CEO: Rickard Zilliacus
Founders: Rickard Zilliacus, Max Heino, Casper von Pfaler
Founders: Rickard Zilliacus, Max Heino, Casper von Pfaler
Pre-seed round
Measurlabs
CEO: Teemu Myllymäki
Founders: Teemu Myllymäki, Kalle Lagerblom
Founders: Teemu Myllymäki, Kalle Lagerblom
Portfolio events
Akseli Hemminki
Lifeline Ventures
Series A
Tilt Biotherapeutics
Lifeline Ventures led the Series A round in TILT Biotherapeutics (TILT), a clinical-stage biotechnology company developing cancer immunotherapies, with the final close of
EUR 22 million.
Tilt Biotherapeutics
TILT Biotherapeutics is the leading company globally working in the area of enabling tumor T-cell therapy with oncolytic viruses. Advanced solid tumors are difficult to treat with limited treatment options available. However, preclinical data on TILT® technology, alone and in combination with other immunotherapy agents have demonstrated 100% cure rates.
CEO: Akseli Hemminki
Founder: Akseli Hemminki
2013
Founded
2013
Lifeline Ventures
Seed round
2016
Funding round
Led by Springvest
2020
Funding round
Led by Springvest
2023
Lifeline Ventures
Series A
Founded
02/2023
Ninchat
Ninchat is a cloud based communication service for businesses. It can be used for team communication, customer service or live group discussions. Ninchat can be embedded anywhere the end users are – e.g. on a website, mobile site, application or a social media site.
CEO: Ville Mujunen
Founders: Ville Mujunen, Jari Jaanto, Antti Laakso, Heini Björk
2011
Founded
2013
Seed round
2022
Acquired
by Terveystalo
10/2022
Miki Kuusi
Elias Aalto
Juhani Mykkänen
Mika Matikainen
Exited
Wolt
The closing of the acquisition of Wolt by DoorDash Inc. took place in June 2022.
Read moreWolt
Wolt is a technology company building the one app for discovering and getting great food in your city. The Helsinki-based company has operations in +20 countries and +120 cities, serving food from over 10,000 restaurants with over 20,000 courier partners. The company was founded in 2014 and employs over 2,000 people. Wolt was acquired by DoorDash in 2022.
CEO: Miki Kuusi
Founders: Elias Aalto, Juhani Mykkänen, Lauri Andler, Mika Matikainen, Miki Kuusi, Oskari Pétas
2014
Founded
2015
Seed round
2016
Series A
Led by EQT Ventures
2018
Series B
Led by 83North
2019
Series C
Led by Iconiq Capital
2020
Funding round
From Iconiq, Highland, 83North, EQT Ventures and Goldman Sachs
2021
Funding round
Led by Iconiq Growth
2022
Acquired
by DoorDash
06/2022
Exited
Akkurate
Akkurate was exited in June 2022.
Akkurate
Akkurate’s team has a broad experience in battery production chain, battery development and lifecycle management. Services include technology consulting, testing and analysis, specification optimization, charging system design, manufacturing assessments and for example complete technical supplier evaluation.
CEO: Mika Kanninen
Founders: Mika Kanninen, Lauri Pulkkinen, Jari Koskinen, Kimmo Valo
2016
Founded
2016
Lifeline Ventures
Seed round
2020
Funding round
Led by Fortum and Tesi
2022
Acquired
by Sandvik
6/2022